Skip to main content
Top
Published in: Clinical and Translational Oncology 9/2012

01-09-2012 | Editorial

Promises and pitfalls of new technology in radiotherapy

Author: Ferran Guedea

Published in: Clinical and Translational Oncology | Issue 9/2012

Login to get access

Excerpt

The last 50 years have witnessed an explosion in both our understanding of cancer and in the range of treatments to slow or even halt the progression of cancer. Change has accelerated in the last 10 years with the advent of powerful new modalities such as image-guided radiotherapy (IGRT), intensity-modulated radiotherapy (IMRT), and stereotactic body radiotherapy (SBRT). Much of this recent progress is due to increased computing power, which allows for nearly instantaneous dosimetric calculations and real-time imaging. IMRT has been called “the most significant technical advance in radiation therapy since the linear accelerator” [1] and there is no doubt that IMRT is a significant improvement over 3D-CRT, which, until very recently, was the standard of care [2, 3]. …
Literature
2.
go back to reference Herruzo I, Romero J, Palacios A (2011) The white book of radiation oncology in Spain. Clin Transl Oncol 13(6):385–395PubMedCrossRef Herruzo I, Romero J, Palacios A (2011) The white book of radiation oncology in Spain. Clin Transl Oncol 13(6):385–395PubMedCrossRef
3.
go back to reference Bindhu J, Supe S, Pawar Y (2009) Intensity modulated radiotherapy (IMRT) the white, black and grey: a clinical perspective. Rep Pract Onco Radiother 14(3):95–103CrossRef Bindhu J, Supe S, Pawar Y (2009) Intensity modulated radiotherapy (IMRT) the white, black and grey: a clinical perspective. Rep Pract Onco Radiother 14(3):95–103CrossRef
4.
go back to reference Purdie TG, Dinniwell RE, Letourneau D, Hill C, Sharpe MB (2011) Automated planning of tangential breast intensity-modulated radiotherapy using heuristic optimization. Int J Radiat Oncol Biol Phys 81(2):575–583PubMedCrossRef Purdie TG, Dinniwell RE, Letourneau D, Hill C, Sharpe MB (2011) Automated planning of tangential breast intensity-modulated radiotherapy using heuristic optimization. Int J Radiat Oncol Biol Phys 81(2):575–583PubMedCrossRef
5.
go back to reference Staffurth J (2010) A review of the clinical evidence for intensity-modulated radiotherapy. Clin Oncol 22(8):643–657CrossRef Staffurth J (2010) A review of the clinical evidence for intensity-modulated radiotherapy. Clin Oncol 22(8):643–657CrossRef
7.
go back to reference Liao ZX, Komaki RR, Thames HD Jr, Liu HH, Tucker SL, Mohan R et al (2010) Influence of technologic advances on outcomes in patients with unresectable, locally advanced non-small-cell lung cancer receiving concomitant chemoradiotherapy. Int J Radiat Oncol Biol Phys 76(3):775–781PubMedCrossRef Liao ZX, Komaki RR, Thames HD Jr, Liu HH, Tucker SL, Mohan R et al (2010) Influence of technologic advances on outcomes in patients with unresectable, locally advanced non-small-cell lung cancer receiving concomitant chemoradiotherapy. Int J Radiat Oncol Biol Phys 76(3):775–781PubMedCrossRef
8.
go back to reference Lanni TB Jr, Grills IS, Kestin LL, Robertson JM (2011) Stereotactic radiotherapy reduces treatment cost while improving overall survival and local control over standard fractionated radiation therapy for medically inoperable non-small-cell lung cancer. Am J Clin Oncol 34(5):494–498PubMedCrossRef Lanni TB Jr, Grills IS, Kestin LL, Robertson JM (2011) Stereotactic radiotherapy reduces treatment cost while improving overall survival and local control over standard fractionated radiation therapy for medically inoperable non-small-cell lung cancer. Am J Clin Oncol 34(5):494–498PubMedCrossRef
9.
go back to reference Guedea F (2011) Recent developments in brachytherapy. Rep Pract Onco Radiother 16(6):203–206CrossRef Guedea F (2011) Recent developments in brachytherapy. Rep Pract Onco Radiother 16(6):203–206CrossRef
10.
go back to reference Guedea F (2012) López Torrecilla J, Londres B, Ventura M, Bilbao P, Borràs J. Patterns of care for brachytherapy in Europe: updated results for Spain. Clin Trans. Oncol 14(1):36–42 Guedea F (2012) López Torrecilla J, Londres B, Ventura M, Bilbao P, Borràs J. Patterns of care for brachytherapy in Europe: updated results for Spain. Clin Trans. Oncol 14(1):36–42
12.
go back to reference Njeh CF, Langton CM, Orton CG (2011) The adoption of new technology in radiation oncology should rely on evidence-based medicine. Med Phys 38(6):2825PubMedCrossRef Njeh CF, Langton CM, Orton CG (2011) The adoption of new technology in radiation oncology should rely on evidence-based medicine. Med Phys 38(6):2825PubMedCrossRef
13.
go back to reference Fairchild A, Barnes E, Ghosh S, Ben-Josef E, Roos D, Hartsell W et al (2009) International patterns of practice in palliative radiotherapy for painful bone metastases: evidence-based practice? Int J Radiat Oncol Biol Phys 75(5):1501–1510PubMedCrossRef Fairchild A, Barnes E, Ghosh S, Ben-Josef E, Roos D, Hartsell W et al (2009) International patterns of practice in palliative radiotherapy for painful bone metastases: evidence-based practice? Int J Radiat Oncol Biol Phys 75(5):1501–1510PubMedCrossRef
14.
go back to reference Van de Werf E, Verstraete J, Lievens Y (2012) The cost of radiotherapy in a decade of technology evolution. Radiother Oncol 102(1):148–153PubMedCrossRef Van de Werf E, Verstraete J, Lievens Y (2012) The cost of radiotherapy in a decade of technology evolution. Radiother Oncol 102(1):148–153PubMedCrossRef
15.
go back to reference Sullivan R, Peppercorn J, Sikora K, Zalcberg J, Meropol NJ, Amir E et al (2011) Delivering affordable cancer care in high-income countries. Lancet Oncol 12(10):933–980PubMedCrossRef Sullivan R, Peppercorn J, Sikora K, Zalcberg J, Meropol NJ, Amir E et al (2011) Delivering affordable cancer care in high-income countries. Lancet Oncol 12(10):933–980PubMedCrossRef
16.
go back to reference Smith BD, Haffty BG, Wilson LD, Smith GL, Patel AN, Buchholz TA (2010) The future of radiation oncology in the United States from 2010 to 2020: will supply keep pace with demand? J Clin Oncol 28(35):5160–5165PubMedCrossRef Smith BD, Haffty BG, Wilson LD, Smith GL, Patel AN, Buchholz TA (2010) The future of radiation oncology in the United States from 2010 to 2020: will supply keep pace with demand? J Clin Oncol 28(35):5160–5165PubMedCrossRef
17.
go back to reference Mendenhall WM, Mancuso AA (2009) Radiotherapy for head and neck cancer—is the “next level” down? Int J Radiat Oncol Biol Phys 73(3):645–646 Mendenhall WM, Mancuso AA (2009) Radiotherapy for head and neck cancer—is the “next level” down? Int J Radiat Oncol Biol Phys 73(3):645–646
Metadata
Title
Promises and pitfalls of new technology in radiotherapy
Author
Ferran Guedea
Publication date
01-09-2012
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 9/2012
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-012-0905-0

Other articles of this Issue 9/2012

Clinical and Translational Oncology 9/2012 Go to the issue

EDUCATIONAL SERIES—BLUE SERIES

The association of annexin A2 and cancers

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine